40-51
PROTEIN BASED DRUG DISCOVERY
Authors: Joshi B., Gupta G., Gupta N., Gupta M., Trivedi S., Patil P., Jhadav A., Vamsi K.K., Khairnar Y., Boraste A., Mujapara A.
Number of views: 355
New drug target discovery is currently very popular with a great potential for advancing
biomedical research and chemical genomics. Drug discovery is the process of discovering and designing
drugs that includes target identification, target validation, lead identification, lead optimization and
introduction of the new drugs to the public. G protein-coupled receptors are one of the most important drug
targets. In the current scenario of drug research, approximately 60% of drug target molecules are located at
the cell surface, and half of them are GPCRs. Fragment-based drug discovery is established as an
alternative approach to high-throughput screening for generating novel small molecule drug candidates.
Nanotechnology-based drug delivery systems have seen recent popularity due to their favorable physical,
chemical, and biological properties, and great efforts have been made to target nanoDDSs to specific
cellular receptors. Protein-protein interactions regulate a wide variety of important cellular pathways, and
therefore represent a highly populated class of targets for drug discovery. An analysis of individual proteinprotein
interaction systems has recently yielded success in the discovery of drug-like inhibitors.